LoadingLoadingCookies show us what works. Privacy
Cookies show us what works. Privacy
LoadingCookies show us what works. Privacy
23 funds hold it · Insiders net buying
Net buying: insiders sold $2.7M and bought $181.3M on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Nov 12, 2026
Period ending
Sep 30, 2026
Earnings per share
-$1.01 expected
Revenue
Yahoo Finance
Estimates as of Nov 13, 2026
EPS expected
-$1.11 to -$0.89
Last 30 days
Analysts raising estimates
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Nov 12, 2026 | -$1.05est. -$1.01 | -3.89%miss | $0.00Yahoo Finance | No year-ago quarter |
| Jun 30, 2026Reported Aug 13, 2026 | -$1.05est. -$0.96 | -9.85%miss | $0.00Alpha Vantage | No year-ago quarter |
| Mar 31, 2026Reported May 7, 2026 | -$0.94est. -$1.01 | +7.07%beat | $0.00Alpha Vantage | No year-ago quarter |
| Dec 31, 2025Reported Mar 31, 2026 | -$1.04est. -$1.05 | +1.25%beat | $0.00Alpha Vantage | -100.0%from $26.7M |
| Sep 30, 2025Reported Nov 13, 2025 | -$1.16est. -$1.04 | -11.54%miss | $0.00Alpha Vantage | No year-ago quarter |
| Jun 30, 2025Reported Aug 13, 2025 | -$1.03est. -$1.05 | +1.90%beat | $0.00Alpha Vantage | No year-ago quarter |
| Mar 31, 2025Reported May 14, 2025 | -$1.09est. -$0.87 | -25.29%miss | $0.00Alpha Vantage | No year-ago quarter |
| Dec 31, 2024Reported Mar 27, 2025 | -$0.84est. -$0.86 | +2.78%beat | $26.7MAlpha Vantage | No year-ago quarter |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $0 | $0 | $0 | $0 |
| Cost of what it sold | $6.5M | -$19.8M | $6.3M | — |
| Gross profit | -$6.5M | $19.8M | -$6.3M | — |
| What it spent | ||||
| Research and development | $50.5M | $45.5M | $48.5M | $56.1M |
| Sales and admin | $11.9M | $12.0M | $11.2M | $10.8M |
| Total operating expenses | $62.4M | $57.5M | $59.8M | $66.8M |
| What was left | ||||
| Operating profit | -$62.4M | -$57.5M | -$59.8M | -$66.8M |
| Profit before tax | -$61.5M | -$56.7M | -$58.2M | -$65.6M |
| Net profit | -$61.5M | -$56.7M | -$58.2M | -$65.6M |
| EBITDA | -$54.9M | -$46.5M | -$51.8M | -$60.6M |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Kodiak Sciences CEO to present at major healthcare conferences in Nov-Dec 2026
Leans bullishNov 12Kodiak Sciences to Present at Three Upcoming Investor Conferences
NeutralNov 11Kodiak Sciences stock trades at 96.26 euros in late session
NeutralNov 10Kodiak Sciences stock hits 52-week high at 104.26 USD By Investing.com
BullishNov 9Kodiak Sciences (KOD) Could Be 23% Undervalued On Its Retina Pipeline Story
BullishNov 9Form 4 Kodiak Sciences Inc: BAKER BROS. ADVISORS LP (Director, 10% Owner) For: 4 November
NeutralNov 7At $98.51 a share, two funds buy Kodiak Sciences (KOD) stock.
BullishNov 6Kodiak Sciences Inc. (KOD) Seasonal Returns Chart - Yahoo Finance
NeutralOct 3122 macro signals shaping KOD right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
